If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Taltz ® (ixekizumab) injection80 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TALTZ® (ixekizumab): Maintenance of Response in Plaque Psoriasis
Date of Last Review: June 16, 2021